MTOR and renal carcinoma: Considering the differential intrinsic expression and potentially differential PD-1/PD-L1 interaction intensity within the two (clear and papillary) types of renal carcinoma, one could speculate the activation of different signaling pathways (PI3K/AKT, MAPK, mTOR).